Skip to main content

Advertisement

Table 1 Clinical and pathological characteristics of the patient cohort

From: CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer

  Positive Negative   
Estrogen-Receptor 175 (72%) 68 (28%)   
Progestrone-Receptor 136 (56%) 108 (44%)   
HER2-positive (over-expressed) 20 (14%) 121 (86%)   
Ki67-positive (>14% positivity) 84 (60%) 55 (40%)   
  1986–1991 1991–1996 1996–2001 2001–2004
Year of Diagnosis 81 (30%) 121 (46%) 60 (23%) 3 (1%)
  26–42 42–58 58–74 74–91
Age at Diagnosis 36 (14%) 104 (39%) 80 (30%) 45 (17%)
  5–30 30–55 55–80 80–100
Tumour size (mm) 94 (77%) 24 (20%) 1 (1%) 3 (2%)
Nodal status 112 (64%) 63 (36%)   
  + ++ +++  
Histological Grade 19 (13%) 62 (41%) 69 (46%)